Correlation Between Protalix Biotherapeutics and Codexis

Can any of the company-specific risk be diversified away by investing in both Protalix Biotherapeutics and Codexis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protalix Biotherapeutics and Codexis into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Protalix Biotherapeutics and Codexis, you can compare the effects of market volatilities on Protalix Biotherapeutics and Codexis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protalix Biotherapeutics with a short position of Codexis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protalix Biotherapeutics and Codexis.

Diversification Opportunities for Protalix Biotherapeutics and Codexis

0.18

Correlation Coefficient

Protalix Biotherapeutics  Codexis

Average diversification

The 3 months correlation between Protalix and Codexis is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Protalix Biotherapeutics and Codexis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Codexis and Protalix Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protalix Biotherapeutics are associated (or correlated) with Codexis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Codexis has no effect on the direction of Protalix Biotherapeutics i.e., Protalix Biotherapeutics and Codexis go up and down completely randomly.

Pair Corralation between Protalix Biotherapeutics and Codexis

Considering the 90-day investment horizon Protalix Biotherapeutics is expected to generate 1.18 times more return on investment than Codexis. However, Protalix Biotherapeutics is 1.18 times more volatile than Codexis. It trades about 0.05 of its potential returns per unit of risk. Codexis is currently generating about -0.15 per unit of risk. If you would invest  162.00  in Protalix Biotherapeutics on August 26, 2025 and sell it today you would earn a total of  13.00  from holding Protalix Biotherapeutics or generate 8.02% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	96.88%
Values	Daily Returns

Protalix Biotherapeutics  vs.  Codexis

Protalix Biotherapeutics

Risk-Adjusted Performance

Soft

Compared to the overall equity markets, risk-adjusted returns on investments in Protalix Biotherapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting essential indicators, Protalix Biotherapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Codexis

Risk-Adjusted Performance

Weakest

Over the last 90 days Codexis has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Protalix Biotherapeutics and Codexis

The main advantage of trading using opposite Protalix Biotherapeutics and Codexis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protalix Biotherapeutics position performs unexpectedly, Codexis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Codexis will offset losses from the drop in Codexis' long position.

The idea behind Protalix Biotherapeutics and Codexis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.